Wide Ranks

GLSI

Greenwich LifeSciences, Inc.

14.57

Top Statistics
Market Cap 191 M Forward PE -17.77 Revenue Growth 0.00 %
Current Ratio 5.34 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -16.27 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 7 M Total Cash Per Share 0.5500 Total Debt
Total Debt To Equity Current Ratio 5.34 Book Value Per Share 0.5220
All Measures
Short Ratio 2141.00 % Message Board Id finmb_653283398 Shares Short Prior Month 495729
Return On Equity -1.24 City Stafford Uuid 4e2e7791-071b-3035-8903-9649195950f2
Previous Close 14.35 First Trade Date Epoch Utc 1 B Book Value 0.5220
Beta 3.32 Volume 20524 Price To Book 27.91
Fifty Two Week Low 8.00 Total Cash Per Share 0.5500 Shares Short Previous Month Date 1 B
Target Median Price 38.00 Audit Risk 10 Max Age 86400
Sand P52 Week Change 0.3133 Target Mean Price 38.00 Net Income To Common -10218405
Short Percent Of Float 0.0783 Implied Shares Outstanding 13 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 30520 Average Volume10days 30520
Total Cash 7 M Next Fiscal Year End 1 B Held Percent Insiders 0.5293
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Share Holder Rights Risk 4 Regular Market Previous Close 14.35 Target Low Price 38.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 13.81 Open 14.50
Free Cashflow -3152795 State TX Dividend Yield 0.00 %
Return On Assets -0.7245 Time Zone Short Name EST Board Risk 10
Trailing Eps -0.8100 Day Low 14.23 Address1 Building 14
Shares Outstanding 13 M Compensation Risk 8 Price Hint 2
Target High Price 38.00 Website https://greenwichlifesciences.com 52 Week Change 0.2453
Average Volume 30810 Forward Eps -0.8200 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 534.00 % Is_sp_500 False
Regular Market Day High 14.64 Profit Margins 0.00 % Fifty Two Week High 21.44
Day High 14.64 Shares Short 484599 Regular Market Open 14.50
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0369 Operating Cashflow -6785223 Currency USD
Time Zone Full Name America/New_York Market Cap 191 M Is_nasdaq_100 False
Zip 77477 Quote Type EQUITY Industry Biotechnology
Long Name Greenwich LifeSciences, Inc. Overall Risk 10 Regular Market Day Low 14.23
Held Percent Institutions 0.0870 Current Price 14.57 Address2 3992 Bluebonnet Drive
Enterprise To Ebitda -16.27 Financial Currency USD Current Ratio 5.34
Industry Disp Biotechnology Number Of Analyst Opinions 1 Country United States
Float Shares 5 M Two Hundred Day Average 14.60 Governance Epoch Date 1 B
Enterprise Value 171 M Forward PE -17.77 Regular Market Volume 20524
Ebitda -10533951 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.

Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery.

The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018.

Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.